$LONN-CH News
Last published 5y ago
- 5y agoMRNAPFEBNTXLONN-CHModerna's vaccine maker identifies the 'big challenges' to mass producing the coronavirus vaccineCNBCManufacturing sites, skilled personnel and temperature control — just some of the challenges facing vaccine makers now.
- 6y agoGSK-GBLONN-CHMRNASAN-FRTrump's coronavirus vaccine czar says has had 'enough' of Democratic calls for his firing over pharma stock holdingsCNBCSlaoui admitted in a phone interview with CNBC that he still holds shares in GlaxoSmithKline, where he worked for nearly 30 years and will use as part of his retirement.
- 6y agoMRNAJNJMRKLONN-CHModerna CEO sees 'high probability' of success with Covid-19 vaccineCNBCModerna is the front-runner in the race for a Covid-19 vaccine. Its CEO sees an 80% to 90% chance of success.
- 6y agoMRNALONN-CHDr. Fauci is still confident U.S. could have a coronavirus vaccine by DecemberCNBCResearchers are accelerating development of vaccine candidates by simultaneously investing in multiple stages of development that could prove to be useless if the vaccine ends up not being effective or safe, Fauci said.
- 6y agoMRNALONN-CHModerna CEO says supply of coronavirus vaccine will be limited, US will help decide who gets it firstCNBC"We will all be supply constrained for quite some time, meaning we won't be able to make as many product as will be required to vaccinate everyone on the planet," CEO Stephane Bancel said on CNBC's "Squawk Box."
- 6y agoROG-CHREGNSAN-FRMRNA+4Pharma giants granted coronavirus approvals but doubts remain on manufacturing a global vaccineCNBCExperts warn that vaccine timelines look ambitious and argue more thought is needed on manufacturing.
- 6y agoMRNALONN-CHModerna could begin manufacturing unproven coronavirus vaccine in July, CEO saysCNBCThe race to develop a vaccine is intensely competitive and investors are watching closely for signs of progress on treatments and vaccines.